TYROSINE PHOSPHORYLATION OF P160 BCR BY P210 BCR-ABL

被引：0
|
作者：
LU, D
LIU, JX
CAMPBELL, M
GUO, JQ
HEISTERKAMP, N
GROFFEN, J
CANAANI, E
ARLINGHAUS, R
机构：
[1] UNIV TEXAS, MD ANDERSON CANC CTR,DEPT MOLEC PATHOL,BOX 89, 1515 HOLCOMBE BLVD, HOUSTON, TX 77030 USA
[2] CHILDRENS HOSP LOS ANGELES, DEPT PATHOL, MOLEC DIAG SECT, LOS ANGELES, CA USA
[3] WEIZMANN INST SCI, DEPT CHEM IMMUNOL, IL-76100 REHOVOT, ISRAEL
来源：
BLOOD | 1993年 / 82卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1257 / 1263
页数：7
相关论文
共 50 条
  • [31] Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
    Scrideli, Carlos Alberto
    de Oliveira, Fabio Morato
    Brassesco, Maria Sol
    Queiroz, Rosane de Paula
    Bernardes, Jose Eduardo
    Valera, Elvis Terci
    Tone, Luiz Gonzaga
    LEUKEMIA RESEARCH, 2009, 33 (03) : 495 - 499
  • [32] HIERARCHY OF C-MYC TRANSCRIPTIONAL ACTIVATION BY P21 RAS AND BY P210 BCR-ABL
    BOSWELL, HS
    LITZJACKSON, S
    BURGESS, GS
    LEIBOWITZ, D
    MILLER, AH
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 795 - 795
  • [33] Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation
    Score, J.
    Calasanz, M. J.
    Ottman, O.
    Pane, F.
    Yeh, R. F.
    Sobrinho-Simoes, M. A.
    Kreil, S.
    Ward, D.
    Hidalgo-Curtis, C.
    Melo, J. V.
    Wiemels, J.
    Nadel, B.
    Cross, N. C. P.
    Grand, F. H.
    LEUKEMIA, 2010, 24 (10) : 1742 - 1750
  • [34] All common p210 and p190 Bcr-abl variants can be targeted by RNA interference
    L Wohlbold
    H van der Kuip
    A Moehring
    G Granot
    M Oren
    H-P Vornlocher
    W E Aulitzky
    Leukemia, 2005, 19 : 290 - 292
  • [35] Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia
    Lichty, BD
    Keating, A
    Callum, J
    Yee, K
    Croxford, R
    Corpus, G
    Nwachukwu, B
    Kim, P
    Guo, J
    Kamel-Reid, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (03) : 711 - 715
  • [36] Contributions of the RhoGEF activity of p210 BCR/ABL to disease progression
    Tala, I.
    Chen, R.
    Hu, T.
    Fitzpatrick, E. R.
    Williams, D. A.
    Whitehead, I. P.
    LEUKEMIA, 2013, 27 (05) : 1080 - 1089
  • [37] Contributions of the RhoGEF activity of p210 BCR/ABL to disease progression
    I Tala
    R Chen
    T Hu
    E R Fitzpatrick
    D A Williams
    I P Whitehead
    Leukemia, 2013, 27 : 1080 - 1089
  • [38] Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells:: respective roles of Vav and Bcr-Abl GEFs
    Daubon, T.
    Chasseriau, J.
    El Ali, A.
    Rivet, J.
    Kitzis, A.
    Constantin, B.
    Bourmeyster, N.
    ONCOGENE, 2008, 27 (19) : 2673 - 2685
  • [39] Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs
    T Daubon
    J Chasseriau
    A El Ali
    J Rivet
    A Kitzis
    B Constantin
    N Bourmeyster
    Oncogene, 2008, 27 : 2673 - 2685
  • [40] P190 and P210 Transcripts of BCR-ABL Gene Rearrangements in Refractory and Relapsed Acute Lymphoblastic Leukaemia
    Soe, N. Nwe
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S398 - S398
12345